Search
Close this search box.

Home > Applications > AgBio

AgBio

As you grow, so do our solutions

Helping you screen and uncover more than ever before - Decode Science offers a full workflow for the genomic testing of plants and animals

Agricultural genetic biology testing involves analysing the genetic makeup of plants, animals, and microorganisms to improve agricultural productivity, sustainability, and resilience. This testing encompasses various techniques, including genotyping, sequencing, and molecular marker analysis, to identify desirable traits, such as disease resistance, drought tolerance, and high yield potential. It also includes the routine screening of plants for ID purposes and for pathogens to ensure environments and crops remain pest and disease free.

Decode Science can assist AgBio groups to improve their outcomes by working together on their workflow. From automation and sequencers, library prep and extraction kits, quality control and more. At Decode Science, we pride ourselves on the level of flexibility, customisation, and collaboration we bring when working together to come up with a solution that improves outcomes for you and your clients.

Crop Improvement

Identifying and selecting plants with beneficial genetic traits for breeding programs aimed at developing new varieties with improved agronomic performance, nutritional quality, and stress tolerance.

Livestock Genetics

Assessing the genetic diversity and health of livestock populations, identifying genetic markers associated with desirable traits (e.g., meat quality, milk production), and implementing selective breeding strategies to enhance productivity and animal welfare.

Disease Resistance

Screening plants and animals for genetic resistance to pests, pathogens, and diseases, enabling the development of resistant cultivars and breeds to reduce the need for chemical pesticides and antibiotics.

Environmental Sustainability

Studying the genetic basis of traits related to resource use efficiency, such as nitrogen fixation in legumes or water use efficiency in crops, to optimise agricultural practices and minimise environmental impact.

Precision Agriculture

Using genetic information to tailor farming practices, such as fertiliser application, irrigation scheduling, and pest management, to specific genetic profiles, soil conditions, and environmental factors, maximising yield while minimizing inputs.

High-efficiency guide RNAs for knockouts and knock-ins.
CRISPR experts agree that using synthetic single guide RNAs (sgRNAs) for genome engineering generate more efficient and consistent editing results than any other type of guide RNAs.
Synthego sgRNAs are highly pure guides that deliver indel frequencies of up to 99%, making it easy to efficiently conduct knockout or knock-ins in virtually any cell type. Their sgRNAs can be ordered with site-specific chemical modifications that provide greater stability and decreased activation of the cellular innate immune response.
Twist Bioscience

Twist Bioscience

Twist Bioscience, headquartered in South San Francisco, is a prominent biotechnology company specializing in the manufacture of synthetic DNA and DNA products for diverse industries. Established in 2013 by Emily Leproust, Bill Banyai, and Bill Peck, Twist Bioscience has quickly emerged as a leader in the field.

In March 2021, the company was represented by Emily Leproust at a tabletop exercise during the Munich Security Conference. The simulation focused on an outbreak of weaponized monkeypox, showcasing Twist Bioscience's involvement in addressing critical global challenges. In May 2021, Twist Bioscience collaborated with the Genome Project-Write to launch a groundbreaking Computer-Aided Design (CAD) platform for whole genome design. This innovative platform automates workflows, facilitating collaborative efforts essential for scaling up genome design—from designing plasmids to megabases across entire genomes. This initiative marks a significant advancement in genomic research and underscores Twist Bioscience's commitment to driving progress through technology and collaboration.

LEARN MORE >

MGI

MGI

MGI, also known as MGI Tech, is a prominent Chinese biotechnology company specializing in a comprehensive array of products and technologies catering to the genetic sequencing, genotyping, gene expression, and proteomics markets. Headquartered in Shenzhen, China, MGI has established itself as a leading provider of innovative solutions to meet the evolving needs of the biotechnology and life sciences industries. With its diverse product line and cutting-edge technologies, MGI is dedicated to advancing research and applications in genomics and proteomics fields, contributing to scientific breakthroughs and advancements worldwide.

LEARN MORE >

STOmics

STOmics stands at the forefront of advancing spatially-resolved transcriptomic analysis through its revolutionary SpaTial Enhanced REsolution Omics-Sequencing (Stereo-seq) technology. Leveraging proprietary Stereo-seq technology, which is built on DNA Nanoball (DNB) technology, researchers gain access to a groundbreaking tool for exploring spatial biology with unparalleled field-of-view and resolution.

Stereo-seq operates in square-centimeter units, with the standard 1x1 cm RNA capture unit utilizing the STOmics-GeneExpression-S1 Chip. This innovative chip combines centimeter-scale field-of-view in situ capture of comprehensive transcriptome information with nanoscale resolution, resulting in unmatched quality of spatial transcriptomic analysis.

LEARN MORE >

seqWell

seqWell is on a mission to redefine NGS library preparation, unlocking the full potential of today's DNA sequencing instruments. At the heart of our innovation lies the plexWell™ platform, a groundbreaking library preparation technology that revolutionizes multiplexing by enabling simple and scalable processing of hundreds to thousands of samples without the need for time- and cost-consuming normalization steps.

The plexWell platform boasts a wide-ranging impact across various applications, including synthetic biology, targeted sequencing, single-cell analysis, and both low- and high-depth sequencing of human, plant, animal, and microbial genomes. By eliminating the complexities associated with traditional library preparation methods, plexWell empowers researchers to accelerate their sequencing workflows while maximizing throughput and efficiency.

LEARN MORE >

Bioptic

BiOptic

BiOptic, Inc. is a pioneering biotechnology instrument company dedicated to the development, manufacturing, and marketing of fully-integrated systems and tests for Fluorescence Immunoassay analysis across various sectors, including research, clinical, and industrial markets. The cutting-edge systems empower rapid and sophisticated Antibody-Antigen interaction testing, automating complex manual laboratory procedures for enhanced efficiency and accuracy.

The user-friendly systems seamlessly integrate multiple intricate and time-consuming steps, such as sample preparation and detection, streamlining the analysis of complex biological samples. Central to the technology are the proprietary pen-size gel-cartridges, which facilitate the efficient processing of samples within the systems.

LEARN MORE >

Synthego logo

Synthego

Synthego is a genome engineering company dedicated to advancing life science research and development for enhanced human health. Leveraging machine learning, automation, and gene editing, Synthego builds scalable platforms for scientific exploration. Rooted in engineering disciplines, its platform technologies seamlessly integrate proprietary hardware, software, bioinformatics, chemistries, and molecular biology. This integration drives progress in basic research, target validation, and clinical trials.

Synthego's technologies have been featured in numerous peer-reviewed publications and are utilized by a multitude of commercial and academic researchers, as well as therapeutic drug developers. By delivering genome editing on an unprecedented scale, Synthego is spearheading innovation in medicine, poised to shape the next generation of treatments.

LEARN MORE >

Jumpcode

Jumpcode Genomics specializes in overcoming technical barriers in genomics, enabling enhanced discovery through its CRISPRclean technology. This patented approach enhances next-generation sequencing by boosting sensitivity, cutting costs, streamlining workflows, and eliminating bias. By reducing noise, researchers can easily pinpoint the genetic information they seek, extracting deeper insights and uncovering novel signals previously obscured by irrelevant sequences. Widely adopted across various fields including basic research, infectious disease, oncology, and consumer genomics, Jumpcode's CRISPRclean technology empowers scientists worldwide to unlock the full potential of genomic data.

LEARN MORE >

Let’s Find You an Application That Helps Your Research

Get a call from your local Decode Science representative to help you find the best fit genomics products for you.